January 22, 2021 20:31 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Youth need to take inspiration from young Indian cricket team’s recent victory: PM Modi | Jammu and Kashmir: Pakistan troops violate ceasefire near LoC in Kupwara | West Bengal: Actor Saurav Das joins Trinamool Congress | Rebel Trinamool Congress leader Rajib Banerjee resigns as Bengal Minister | Assam: Speedy bus mow down school student, angry mob damage vehicle

Delhi resident doctors prefer Covishield over indigenous Covaxin in Covid-19 vaccination drive

New Delhi/IBNS: Within hours after Prime Minister Narendra Modi launched the Covid-19 vaccination drive, the resident doctors of Delhi on Saturday preferred to be inoculated with Oxford vaccine, named Covishield in India, over the indigenous Covaxin.

Covid-19 vaccination drive starts in Assam

Guwahati/UNI: The Covid-19 vaccination drive started in Assam on Saturday along with other parts of the country.

PM Modi launches world's biggest Covid-19 vaccination drive in India

New Delhi/IBNS: Prime Minister Narendra Modi on Saturday launched the world's biggest Covid-19 vaccination drive in India, which is one of the worst Novel Coronavirus-hit countries.

PM Modi to launch pan India Covid-19 vaccination drive at 10:30 AM on Saturday

New Delhi/IBNS: Prime Minister Narendra Modi will launch the pan India rollout of COVID-19 vaccination drive on Jan 16 at 10:30 AM via video conferencing. 

PM Modi likely to inaugurate Coronavirus vaccination drive virtually on Jan 16

New Delhi/IBNS: Prime Minister Narendra Modi is likely to inaugurate the coronavirus vaccination drive virtually on January 16, said media reports.

Covid-19: Bharat Biotech rolls out India's indigenous vaccine Covaxin

Hyderabad/IBNS: A day after the Serum Institute of India (SII) rolled out its vaccine against Covid-19, the first batch of India's indigenous remedy Covaxin, made by Bharat Biotech, left Hyderabad for 11 cities on Wednesday morning, media reports said.

Covid vaccine recipients don't get to choose between two options for now: Centre

New Delhi/IBNS: The Indian government on Tuesday said that no recipient of Covid-19 vaccine gets to choose from the two candidates available in the country for emergency use.

Air India, SpiceJet, GoAir, and IndiGo transport 56.5 lakh doses of SII's Covishield across India

New Delhi/IBNS: The first batches of coronavirus vaccine began rolling out on early Tuesday from the Pune facility of Serum Institute of India with a total of 56.5 lakh doses to be transported during the day by Air India, SpiceJet, GoAir, and IndiGo, said media reports.

India fights COVID-19: First consignment of Covishield vaccines leaves Serum Institute Pune

Pune/UNI: Three temperature-controlled trucks rolled out of the Serum Institute's gates shortly before 5 am and left for Pune airport, from where the vaccines will be flown to different parts of India.

Indian govt signs contract with Serum Institute for 11 million doses of Covishield

New Delhi/IBNS: The government has placed an initial order of 11 million doses of Covishield manufactured by Serum Institute of India (SII), media reports said.

Covishield ready to roll out in coming weeks: SII CEO Adar Poonawalla

New Delhi/UNI: Hours after the Drugs Controller General of India (DGCI) approved Oxford-AstraZeneca COVID-19 vaccine ''Covishield'' for restricted emergency use, Serum Institute of India (SII) CEO Adar Poonawalla announced that the vaccine is ready to roll out in the coming weeks.

India registers 18,177 new Covid-19 cases in last 24 hours, 217 deaths

New Delhi/IBNS: India registered 18,177 fresh infections in the last 24 hours taking the total Coronavirus cases to 1,03,23,965 on Sunday, the Union Health Ministry data showed.

Serum Institute, Bharat Biotech get DCGI approval for emergency use of Covid-19 vaccines

New Delhi/IBNS: Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.

Two Covid-19 vaccine candidates await DCGI approval for emergency use in India

New Delhi/IBNS: Two Covid-19 vaccine candidates in India-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-now awaits the approval of the Drugs Controller General of India (DCGI) for emergency use after they have been cleared by the government-appointed panel.

Govt's expert panel clears Oxford COVID-19 vaccine for India

New Delhi/IBNS: A government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the Serum Institute of India, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).